Trilogy Announces Kurt Johnson’s Retirement
Press Release: 6/29/2022
For Immediate Release
Trilogy Analytical Laboratory is announcing the retirement of President and CEO Kurt Johnson on June 30, 2022.
Although saddened to see Kurt go, Trilogy is overjoyed to see him enter a new phase of life where he may enjoy friends, travel, and most importantly… Family! Kurt Joined Trilogy in 2010 and has been an integral part of Trilogy’s continued success to this day. We at Trilogy are forever grateful for the leadership Kurt has provided and wish him good health and continued success in all his future endeavors.
As Trilogy transitions, we are pleased to announce Carrie Maune as the next President and CEO. We wish her the best of luck.
Trilogy is a food and feed safety laboratory specializing in mycotoxins, mycotoxin binder analysis, biogenic amines and animal drug residue testing. Trilogy Analytical Laboratory opened its doors in 1999 when its founders recognized a need in the mycotoxin industry for quick result turn-around utilizing reliable reference methods provided in an analytical setting. One of the main pillars of Trilogy’s strategy is to operate using a comprehensive quality program that we can rely on to ensure performance parameters are met every single time. From this philosophy the Trilogy line of quality products was born with the mycotoxin industry in mind.